Jody Corbelli

Multivariate prognostic factors analysis for second-line chemotherapy in advanced biliary tract cancer

Lorenzo Fornaro, Stefano Cereda, Giuseppe Aprile et al. · British Journal of Cancer · 2014 · 78 citations · Full text

Medicine, Oncology, Surgery +11

Phase II study of capecitabine-based concomitant chemoradiation followed by durvalumab as a neoadjuvant strategy in locally advanced rectal cancer: the PANDORA trial

Elisa Grassi, Chiara Zingaretti, Elisabetta Petracci et al. · ESMO Open · 2023 · 42 citations · Full text

Medicine, Oncology, Pharmacology +17

Neoadjuvant Treatment in Rectal Cancer: Actual Status

Ingrid Garajová, Stefania Di Girolamo, Francesco De Rosa et al. · Chemotherapy Research and Practice · 2011 · 34 citations · Full text

Medicine, Oncology, Surgery +17

<i>eNOS</i>polymorphisms and clinical outcome in advanced HCC patients receiving sorafenib: final results of the ePHAS study

Andrea Casadei‐Gardini, Giorgia Marisi, Luca Faloppi et al. · Oncotarget · 2016 · 34 citations · Full text

Life Sciences, Genetics, Oncology +9

A phase II study of capecitabine plus concomitant radiation therapy followed by durvalumab (MEDI4736) as preoperative treatment in rectal cancer: PANDORA study final results.

Stefano Tamberi, Grassi Elisa, Chiara Zingaretti et al. · Journal of Clinical Oncology · 2022 · 32 citations

Medicine, Oncology, Pharmacotherapy +16